These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27379703)

  • 1. CEBPA mutation in a case of chronic myeloid leukemia presenting in myeloid blast crisis.
    Yin Y; Li J; Yan W; Cheng Z; Sun N; Zhang G
    Leuk Lymphoma; 2017 Mar; 58(3):708-710. PubMed ID: 27379703
    [No Abstract]   [Full Text] [Related]  

  • 2. A case of near-triploid with t(2;14)(p12;q32) in blast crisis of chronic myeloid leukemia detected by spectral karyotyping (SKY).
    de Oliveira FM; Scrideli CA; Tone LG
    J Pediatr Hematol Oncol; 2007 Apr; 29(4):274-6. PubMed ID: 17414573
    [No Abstract]   [Full Text] [Related]  

  • 3. Prominent hematogone hyperplasia in BCR-ABL1-positive chronic myelogenous leukemia: mimicking recurrent B-lymphoid blast crisis.
    Horna P; Pantazopoulos P; Lancet JE; Moscinski LC; Zhang L
    Leuk Lymphoma; 2014 Aug; 55(8):1952-4. PubMed ID: 24304373
    [No Abstract]   [Full Text] [Related]  

  • 4. Tetrasomy of Philadelphia chromosome in myeloblastic crisis of chronic myelogenous leukemia.
    Oikawa H; Utsugisawa T; Murai K; Narigasawa Y; Miyairi Y; Shimosegawa K; Suzuki T; Kuriya S
    Int J Hematol; 1995 Jun; 61(4):229-30. PubMed ID: 8547613
    [No Abstract]   [Full Text] [Related]  

  • 5. Mutations of the myeloid transcription factor CEBPA are not associated with the blast crisis of chronic myeloid leukaemia.
    Pabst T; Stillner E; Neuberg D; Nimer S; Willman CL; List AF; Melo JV; Tenen DG; Mueller BU
    Br J Haematol; 2006 May; 133(4):400-2. PubMed ID: 16643447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapies with ponatinib and asciminib in a preclinical model of chronic myeloid leukemia blast crisis with compound mutations.
    Curik N; Laznicka A; Polivkova V; Krizkova J; Pokorna E; Semerak P; Suchankova P; Burda P; Hochhaus A; Machova Polakova K
    Leukemia; 2024 Jun; 38(6):1415-1418. PubMed ID: 38615117
    [No Abstract]   [Full Text] [Related]  

  • 7. The beauty and the beast: lymphoma-like morphology of myeloid blast phase in CML.
    Asemissen AM; Dierlamm J
    Blood; 2017 Sep; 130(10):1274. PubMed ID: 28882836
    [No Abstract]   [Full Text] [Related]  

  • 8. Expression of a multidrug resistance gene in blast crisis of chronic myelogenous leukemia.
    Pirker R; Goldstein LJ; Ludwig H; Linkesch W; Lechner C; Gottesman MM; Pastan I
    Cancer Commun; 1989; 1(2):141-4. PubMed ID: 2639725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-existence of Philadelphia chromosome positive acute megakaryoblastic and B-lymphoblastic mixed blast crisis of chronic myeloid leukemia with chronic lymphocytic leukemia.
    Colla S; Sammarelli G; Crugnola M; Ascani S; Sabbatini E; Bonomini S; Hojden M; Craviotto L; De Celis I; Morandi F; Caramatti C; Rizzoli V; Giuliani N
    Eur J Haematol; 2004 May; 72(5):361-5. PubMed ID: 15059073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential mutations causing resistance to both Imatinib Mesylate and Dasatinib in a chronic myeloid leukaemia patient progressing to lymphoid blast crisis.
    Stagno F; Stella S; Berretta S; Massimino M; Antolino A; Giustolisi R; Messina A; Di Raimondo F; Vigneri P
    Leuk Res; 2008 Apr; 32(4):673-4. PubMed ID: 17889935
    [No Abstract]   [Full Text] [Related]  

  • 11. Lymphoid blast crisis at the onset of chronic myelogenous leukaemia: molecular evidence.
    Roman J; Andres P; Jimenez MA; Torres A
    Br J Haematol; 1994 Jul; 87(3):624-6. PubMed ID: 7993807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blast crisis of chronic myeloid leukemia with plasmacytoid dendritic cell phenotype associated with a rare fusion transcript, e13a3 BCR-ABL1.
    Xu D; Claudiani S; Naresh K; Mucklow S; Neelakantan P; Yebra E; Apperley JF; Khorashad J; Milojkovic D
    Leuk Lymphoma; 2019 Dec; 60(12):3090-3091. PubMed ID: 31184233
    [No Abstract]   [Full Text] [Related]  

  • 13. Long duration priapism in blast crisis of chronic myeloid leukemia.
    Dogra PN; Kumar P; Goel R; Dash SC
    J Assoc Physicians India; 2004 Feb; 52():170. PubMed ID: 15656063
    [No Abstract]   [Full Text] [Related]  

  • 14. Bcr-abl positive blast crisis of chronic myeloid leukemia emerging in a case of metastatic colorectal cancer 3 months after completion of an 8-month course of cetuximab and irinotecan.
    Buxhofer-Ausch V; Hinterberger-Fischer M; Hinterberger W
    Eur J Haematol; 2006 May; 76(5):447-8. PubMed ID: 16494624
    [No Abstract]   [Full Text] [Related]  

  • 15. Somatic mutations of PHF6 in patients with chronic myeloid leukemia in blast crisis.
    Li X; Yao H; Chen Z; Wang Q; Zhao Y; Chen S
    Leuk Lymphoma; 2013 Mar; 54(3):671-2. PubMed ID: 22928734
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetic Mutations in a Patient with Chronic Myeloid Leukemia Showing Blast Crisis 10 Years After Presentation.
    Sklarz LM; Wittke C; Krohn S; GROßE-Thie C; Junghanss C; Murua Escobar H; Glaeser H
    Anticancer Res; 2018 Jul; 38(7):3961-3966. PubMed ID: 29970518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Karyotypic findings as an independent prognostic marker in chronic myeloid leukaemia blast crisis.
    Nanjangud G; Kadam PR; Saikia T; Bhisey AN; Kumar A; Gopal R; Chopra H; Nair CN; Advani SH
    Leuk Res; 1994 May; 18(5):385-92. PubMed ID: 8182930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful imatinib and arsenic trioxide combination therapy for sudden onset promyelocytic crisis with t(15;17) in chronic myeloid leukemia.
    Kashimura M; Ohyashiki K
    Leuk Res; 2010 Aug; 34(8):e213-4. PubMed ID: 20299093
    [No Abstract]   [Full Text] [Related]  

  • 19. Blast crisis in chronic myelogenous leukemia remains a difficult therapeutic challenge.
    Nand S; Barton K
    Leuk Lymphoma; 2007 Feb; 48(2):215-6. PubMed ID: 17325875
    [No Abstract]   [Full Text] [Related]  

  • 20. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.
    Druker BJ; Sawyers CL; Kantarjian H; Resta DJ; Reese SF; Ford JM; Capdeville R; Talpaz M
    N Engl J Med; 2001 Apr; 344(14):1038-42. PubMed ID: 11287973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.